10-Q Filing

ALIGNMENT HEALTHCARE, INC. CIK: 1832466 Q2 2023

Filing Information

Form Type	10-Q
Accession Number	`0000950170-23-038000`
Period End Date	20230630
Filing Date	20230803
Fiscal Year	2023
Fiscal Period	Q2
XBRL Instance	alhc-20230630_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 77 Income Statement 76 Cash Flow Statement 81 Stockholders Equity 35

Balance Sheet 77 line items

Line Item	Tag	Value	Unit	Period
Allowance for credit losses	`AllowanceForDoubtfulAccountsReceivableCurrent`	$51.00K	USD	Point-in-time
Allowance for credit losses	`AllowanceForDoubtfulAccountsReceivableCurrent`	-	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	100.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	100.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$409.55M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$453.23M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$395.26M	USD	Point-in-time
Accounts receivable (less allowance for credit losses of $51 at June 30, 2023 and $0 at December 31, 2022, respectively)	`AccountsReceivableNetCurrent`	$88.92M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Accounts receivable (less allowance for credit losses of $51 at June 30, 2023 and $0 at December 31, 2022, respectively)	`AccountsReceivableNetCurrent`	$92.89M	USD	Point-in-time
Short-term investments	`ShortTermInvestments`	$122.25M	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Short-term investments	`ShortTermInvestments`	-	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$77.19M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$42.11M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$544.55M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$683.62M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	1.00B	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	1.00B	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$37.17M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	187.28M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$43.03M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	188.51M	shares	Point-in-time
Right of use asset, net	`OperatingLeaseRightOfUseAsset`	$10.61M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	187.28M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	188.51M	shares	Point-in-time
Right of use asset, net	`OperatingLeaseRightOfUseAsset`	$5.83M	USD	Point-in-time
Goodwill and intangible assets, net	`IntangibleAssetsNetIncludingGoodwill`	$40.13M	USD	Point-in-time
Goodwill and intangible assets, net	`IntangibleAssetsNetIncludingGoodwill`	$40.29M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$6.04M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$6.15M	USD	Point-in-time
Total assets	`Assets`	$783.55M	USD	Point-in-time
Total assets	`Assets`	$633.86M	USD	Point-in-time
Medical expenses payable	`MedicalExpensesPayableCurrent`	$207.20M	USD	Point-in-time
Medical expenses payable	`MedicalExpensesPayableCurrent`	$170.13M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$21.27M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$31.98M	USD	Point-in-time
Deferred premium revenue	`ContractWithCustomerLiabilityCurrent`	$147.48M	USD	Point-in-time
Deferred premium revenue	`ContractWithCustomerLiabilityCurrent`	$308.00K	USD	Point-in-time
Accrued compensation	`AccruedCompensation`	$27.54M	USD	Point-in-time
Accrued compensation	`AccruedCompensation`	$25.91M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$401.85M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$229.96M	USD	Point-in-time
Long-term debt, net of debt issuance costs	`LongTermDebtNoncurrent`	$160.90M	USD	Point-in-time
Long-term debt, net of debt issuance costs	`LongTermDebtNoncurrent`	$161.38M	USD	Point-in-time
Long-term portion of lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$9.21M	USD	Point-in-time
Long-term portion of lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$3.70M	USD	Point-in-time
Total liabilities	`Liabilities`	$572.43M	USD	Point-in-time
Total liabilities	`Liabilities`	$394.56M	USD	Point-in-time
Commitments and Contingencies (Note 12)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and Contingencies (Note 12)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, $.001 par value; 100,000,000 and 100,000,000 shares authorized as of June 30, 2023 and December 31, 2022, respectively; no shares issued and outstanding as of June 30, 2023 and December 31, 2022	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $.001 par value; 100,000,000 and 100,000,000 shares authorized as of June 30, 2023 and December 31, 2022, respectively; no shares issued and outstanding as of June 30, 2023 and December 31, 2022	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $.001 par value; 1,000,000,000 shares authorized as of June 30, 2023 and December 31, 2022; 188,512,765 and 187,280,015 shares issued and outstanding as of June 30, 2023 and December 31, 2022, respectively	`CommonStockValue`	$188.00K	USD	Point-in-time
Common stock, $.001 par value; 1,000,000,000 shares authorized as of June 30, 2023 and December 31, 2022; 188,512,765 and 187,280,015 shares issued and outstanding as of June 30, 2023 and December 31, 2022, respectively	`CommonStockValue`	$187.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$1.01B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$970.18M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-732.24M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-798.00M	USD	Point-in-time
Total Alignment Healthcare, Inc. stockholders' equity	`StockholdersEquity`	$209.98M	USD	Point-in-time
Total Alignment Healthcare, Inc. stockholders' equity	`StockholdersEquity`	$238.13M	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$1.18M	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$1.13M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$239.30M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$293.29M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$306.06M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$293.70M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$223.94M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$211.11M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$633.86M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$783.55M	USD	Point-in-time

Income Statement 76 line items

Line Item	Tag	Value	Unit	Period
Earned premiums	`PremiumsEarnedNet`	$711.47M	USD	2 Qtrs
Earned premiums	`PremiumsEarnedNet`	$456.88M	USD	1 Quarter
Earned premiums	`PremiumsEarnedNet`	$891.69M	USD	2 Qtrs
Earned premiums	`PremiumsEarnedNet`	$366.18M	USD	1 Quarter
Other	`RevenueNotFromContractWithCustomer`	$5.50M	USD	1 Quarter
Other	`RevenueNotFromContractWithCustomer`	$528.00K	USD	2 Qtrs
Other	`RevenueNotFromContractWithCustomer`	$9.85M	USD	2 Qtrs
Other	`RevenueNotFromContractWithCustomer`	$294.00K	USD	1 Quarter
Total revenues	`Revenues`	$366.47M	USD	1 Quarter
Total revenues	`Revenues`	$462.38M	USD	1 Quarter
Total revenues	`Revenues`	$712.00M	USD	2 Qtrs
Total revenues	`Revenues`	$901.53M	USD	2 Qtrs
Medical expenses	`MedicalExpenses`	$611.03M	USD	2 Qtrs
Medical expenses	`MedicalExpenses`	$307.27M	USD	1 Quarter
Medical expenses	`MedicalExpenses`	$410.64M	USD	1 Quarter
Medical expenses	`MedicalExpenses`	$806.96M	USD	2 Qtrs
Selling, general, and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$140.61M	USD	2 Qtrs
Selling, general, and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$135.97M	USD	2 Qtrs
Selling, general, and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$70.20M	USD	1 Quarter
Selling, general, and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$61.67M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$8.13M	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$10.12M	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$4.18M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$5.20M	USD	1 Quarter
Total expenses	`OperatingExpenses`	$486.04M	USD	1 Quarter
Total expenses	`OperatingExpenses`	$755.12M	USD	2 Qtrs
Total expenses	`OperatingExpenses`	$957.68M	USD	2 Qtrs
Total expenses	`OperatingExpenses`	$373.12M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-23.66M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-56.15M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-43.12M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-6.65M	USD	1 Quarter
Interest expense	`InterestExpense`	$10.28M	USD	2 Qtrs
Interest expense	`InterestExpense`	$5.26M	USD	1 Quarter
Interest expense	`InterestExpense`	$4.49M	USD	1 Quarter
Interest expense	`InterestExpense`	$8.89M	USD	2 Qtrs
Other expenses (income)	`OtherNonOperatingExpenseIncome`	$-566.00K	USD	2 Qtrs
Other expenses (income)	`OtherNonOperatingExpenseIncome`	$-428.00K	USD	1 Quarter
Other expenses (income)	`OtherNonOperatingExpenseIncome`	$383.00K	USD	2 Qtrs
Other expenses (income)	`OtherNonOperatingExpenseIncome`	$-442.00K	USD	1 Quarter
Total other expenses	`OtherNonoperatingIncomeExpense`	$-9.71M	USD	2 Qtrs
Total other expenses	`OtherNonoperatingIncomeExpense`	$-9.27M	USD	2 Qtrs
Total other expenses	`OtherNonoperatingIncomeExpense`	$-4.83M	USD	1 Quarter
Total other expenses	`OtherNonoperatingIncomeExpense`	$-4.93M	USD	1 Quarter
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-65.86M	USD	2 Qtrs
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-52.40M	USD	2 Qtrs
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-28.49M	USD	1 Quarter
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-11.58M	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	$1.00K	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	$2.00K	USD	2 Qtrs
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	2 Qtrs
Net loss	`ProfitLoss`	$-52.40M	USD	2 Qtrs
Net loss	`ProfitLoss`	$-65.86M	USD	2 Qtrs
Net loss	`ProfitLoss`	$-28.49M	USD	1 Quarter
Net loss	`ProfitLoss`	$-11.58M	USD	1 Quarter
Less: Net loss attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-17.00K	USD	1 Quarter
Less: Net loss attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	-	USD	2 Qtrs
Less: Net loss attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	-	USD	1 Quarter
Less: Net loss attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-104.00K	USD	2 Qtrs
Net loss attributable to Alignment Healthcare, Inc.	`NetIncomeLoss`	$-65.76M	USD	2 Qtrs
Net loss attributable to Alignment Healthcare, Inc.	`NetIncomeLoss`	$-11.58M	USD	1 Quarter
Net loss attributable to Alignment Healthcare, Inc.	`NetIncomeLoss`	$-28.48M	USD	1 Quarter
Net loss attributable to Alignment Healthcare, Inc.	`NetIncomeLoss`	$-52.40M	USD	2 Qtrs
Total weighted-average common shares outstanding - basic and diluted	`WeightedAverageNumberOfSharesOutstandingNetOfRestrictedSharesOfCommonStockBasicAndDiluted`	185.99M	shares	1 Quarter
Total weighted-average common shares outstanding - basic and diluted	`WeightedAverageNumberOfSharesOutstandingNetOfRestrictedSharesOfCommonStockBasicAndDiluted`	184.56M	shares	2 Qtrs
Total weighted-average common shares outstanding - basic and diluted	`WeightedAverageNumberOfSharesOutstandingNetOfRestrictedSharesOfCommonStockBasicAndDiluted`	180.08M	shares	2 Qtrs
Total weighted-average common shares outstanding - basic and diluted	`WeightedAverageNumberOfSharesOutstandingNetOfRestrictedSharesOfCommonStockBasicAndDiluted`	181.26M	shares	1 Quarter
Net loss per share - basic	`EarningsPerShareBasic`	$-0.36	USD	2 Qtrs
Net loss per share - basic	`EarningsPerShareBasic`	$-0.29	USD	2 Qtrs
Net loss per share - basic	`EarningsPerShareBasic`	$-0.06	USD	1 Quarter
Net loss per share - basic	`EarningsPerShareBasic`	$-0.15	USD	1 Quarter
Net loss per share - diluted	`EarningsPerShareDiluted`	$-0.15	USD	1 Quarter
Net loss per share - diluted	`EarningsPerShareDiluted`	$-0.29	USD	2 Qtrs
Net loss per share - diluted	`EarningsPerShareDiluted`	$-0.06	USD	1 Quarter
Net loss per share - diluted	`EarningsPerShareDiluted`	$-0.36	USD	2 Qtrs

Cash Flow Statement 81 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-52.40M	USD	2 Qtrs
Net loss	`ProfitLoss`	$-65.86M	USD	2 Qtrs
Net loss	`ProfitLoss`	$-28.49M	USD	1 Quarter
Net loss	`ProfitLoss`	$-11.58M	USD	1 Quarter
Provision for credit loss	`ProvisionForDoubtfulAccounts`	$50.00K	USD	1 Quarter
Provision for credit loss	`ProvisionForDoubtfulAccounts`	$51.00K	USD	2 Qtrs
Provision for credit loss	`ProvisionForDoubtfulAccounts`	$58.00K	USD	1 Quarter
Provision for credit loss	`ProvisionForDoubtfulAccounts`	$111.00K	USD	2 Qtrs
(Gain) loss on sublease	`GainLossOnSublease`	$-509.00K	USD	2 Qtrs
(Gain) loss on sublease	`GainLossOnSublease`	$289.00K	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$10.25M	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$8.22M	USD	2 Qtrs
Amortization-investment discount	`InvestmentIncomeAmortizationOfDiscount`	-	USD	2 Qtrs
Amortization-investment discount	`InvestmentIncomeAmortizationOfDiscount`	$1.72M	USD	2 Qtrs
Amortization-debt issuance costs	`AmortizationOfFinancingCosts`	$734.00K	USD	2 Qtrs
Amortization-debt issuance costs	`AmortizationOfFinancingCosts`	$1.14M	USD	2 Qtrs
Amortization of payment-in-kind interest	`PaidInKindInterest`	$2.17M	USD	2 Qtrs
Amortization of payment-in-kind interest	`PaidInKindInterest`	-	USD	2 Qtrs
Equity-based compensation	`ShareBasedCompensation`	$37.61M	USD	2 Qtrs
Equity-based compensation	`ShareBasedCompensation`	$40.15M	USD	2 Qtrs
Non-cash lease expense	`OperatingLeaseCost`	$1.35M	USD	2 Qtrs
Non-cash lease expense	`OperatingLeaseCost`	$1.42M	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-3.91M	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$39.61M	USD	2 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$35.08M	USD	2 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$6.59M	USD	2 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$112.00K	USD	2 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$150.00K	USD	2 Qtrs
Medical expenses payable	`IncreaseDecreaseInMedicalExpensesPayable`	$47.98M	USD	2 Qtrs
Medical expenses payable	`IncreaseDecreaseInMedicalExpensesPayable`	$37.06M	USD	2 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$-3.10M	USD	2 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$-9.00M	USD	2 Qtrs
Deferred premium revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$147.17M	USD	2 Qtrs
Deferred premium revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$-53.00K	USD	2 Qtrs
Accrued compensation	`IncreaseDecreaseInAccruedCompensation`	$-1.63M	USD	2 Qtrs
Accrued compensation	`IncreaseDecreaseInAccruedCompensation`	$940.00K	USD	2 Qtrs
Lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$-2.17M	USD	2 Qtrs
Lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$-2.03M	USD	2 Qtrs
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-1.28M	USD	2 Qtrs
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$122.29M	USD	2 Qtrs
Purchase of business, net of cash received	`PaymentsToAcquireAssetsInvestingActivities`	$1.11M	USD	2 Qtrs
Purchase of business, net of cash received	`PaymentsToAcquireAssetsInvestingActivities`	-	USD	2 Qtrs
Purchase of investments	`PaymentsToAcquireInvestments`	$156.94M	USD	2 Qtrs
Purchase of investments	`PaymentsToAcquireInvestments`	$1.10M	USD	2 Qtrs
Sale of investments	`ProceedsFromSaleOfLongtermInvestments`	$36.15M	USD	2 Qtrs
Sale of investments	`ProceedsFromSaleOfLongtermInvestments`	$1.00M	USD	2 Qtrs
Acquisition of property and equipment	`ProceedsFromAcquisitionOfPropertyAndEquipment`	$-10.77M	USD	2 Qtrs
Acquisition of property and equipment	`ProceedsFromAcquisitionOfPropertyAndEquipment`	$-15.85M	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-11.98M	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-136.64M	USD	2 Qtrs
Repurchase of noncontrolling interest	`PaymentsToMinorityShareholders`	$100.00K	USD	2 Qtrs
Repurchase of noncontrolling interest	`PaymentsToMinorityShareholders`	-	USD	2 Qtrs
Contributions from noncontrolling interest holders	`ProceedsFromMinorityShareholders`	$60.00K	USD	2 Qtrs
Contributions from noncontrolling interest holders	`ProceedsFromMinorityShareholders`	-	USD	2 Qtrs
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$60.00K	USD	2 Qtrs
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-100.00K	USD	2 Qtrs
Net decrease in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$-13.37M	USD	2 Qtrs
Net decrease in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$-14.29M	USD	2 Qtrs
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$454.98M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$411.30M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$468.35M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$397.01M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$454.98M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$411.30M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$468.35M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$397.01M	USD	Point-in-time
Cash paid for interest	`InterestPaidNet`	$5.57M	USD	2 Qtrs
Cash paid for interest	`InterestPaidNet`	$8.99M	USD	2 Qtrs
Acquisition of property in accounts payable	`AcquisitionOfPropertyInAccountsPayable`	$42.00K	USD	2 Qtrs
Acquisition of property in accounts payable	`AcquisitionOfPropertyInAccountsPayable`	$232.00K	USD	2 Qtrs
Purchase of business in accounts payable	`CapitalExpendituresIncurredButNotYetPaid`	$240.00K	USD	2 Qtrs
Purchase of business in accounts payable	`CapitalExpendituresIncurredButNotYetPaid`	-	USD	2 Qtrs
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$409.55M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$453.23M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$395.26M	USD	Point-in-time
Restricted cash in other assets	`RestrictedCashAndCashEquivalents`	$1.75M	USD	Point-in-time
Restricted cash in other assets	`RestrictedCashAndCashEquivalents`	$1.75M	USD	Point-in-time
Total	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$454.98M	USD	Point-in-time
Total	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$411.30M	USD	Point-in-time
Total	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$468.35M	USD	Point-in-time
Total	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$397.01M	USD	Point-in-time

Stockholders Equity 35 line items

Line Item	Tag	Value	Unit	Period
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$239.30M	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$293.29M	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$306.06M	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$293.70M	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$223.94M	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$211.11M	USD	Point-in-time
Beginning Balance, Shares	`CommonStockSharesIssued`	187.28M	shares	Point-in-time
Beginning Balance, Shares	`CommonStockSharesIssued`	188.51M	shares	Point-in-time
Net loss	`ProfitLoss`	$-52.40M	USD	2 Qtrs
Net loss	`ProfitLoss`	$-65.86M	USD	2 Qtrs
Net loss	`ProfitLoss`	$-28.49M	USD	1 Quarter
Net loss	`ProfitLoss`	$-11.58M	USD	1 Quarter
Issuance of common stock upon vesting of restricted stock units	`IssuanceOfCommonStockUponVestingOfRestrictedStockUnits`	48,976.00	shares	1 Quarter
Issuance of common stock upon vesting of restricted stock units values	`IssuanceOfCommonStockUponVestingOfRestrictedStockUnitsValues`	$1.00K	USD	2 Qtrs
Issuance of common stock upon vesting of restricted stock units values	`IssuanceOfCommonStockUponVestingOfRestrictedStockUnitsValues`	-	USD	1 Quarter
Forfeitures	`StockIssuedDuringPeriodValueShareBasedCompensationForfeited`	-	USD	1 Quarter
Forfeitures	`StockIssuedDuringPeriodValueShareBasedCompensationForfeited`	-	USD	2 Qtrs
Forfeitures	`StockIssuedDuringPeriodValueShareBasedCompensationForfeited`	-	USD	1 Quarter
Forfeitures	`StockIssuedDuringPeriodValueShareBasedCompensationForfeited`	-	USD	2 Qtrs
Equity-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$37.61M	USD	2 Qtrs
Equity-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$15.64M	USD	1 Quarter
Equity-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$12.10M	USD	1 Quarter
Equity-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$40.15M	USD	2 Qtrs
Repurchase of noncontrolling interest attributable to subsidiary	`MinorityInterestDecreaseFromRedemptions`	$100.00K	USD	2 Qtrs
Repurchase of noncontrolling interest attributable to subsidiary	`MinorityInterestDecreaseFromRedemptions`	$-60.00K	USD	2 Qtrs
Repurchase of noncontrolling interest attributable to subsidiary	`MinorityInterestDecreaseFromRedemptions`	$100.00K	USD	1 Quarter
Noncontrolling interest attributable to subsidiary	`NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance`	$30.00K	USD	1 Quarter
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$239.30M	USD	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$293.29M	USD	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$306.06M	USD	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$293.70M	USD	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$223.94M	USD	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$211.11M	USD	Point-in-time
Ending Balance, Shares	`CommonStockSharesIssued`	187.28M	shares	Point-in-time
Ending Balance, Shares	`CommonStockSharesIssued`	188.51M	shares	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.